Palisade Bio, Inc. Common Stock

PALI XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

340M

Short interest (Jul 15)

21.3%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.52%

↓ 13.8%

Available Shares

↓ 3.6%

Price Chart

Company Overview

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001357459

Asset Type: CS

Market Data

Market Cap: $338,870,356

Employees: 14

Status: Active

Short Interest

Current Borrow Fee 0.52%

Range: 0.52% - 0.55%

Available Shares 9M

Range: 8.8M - 9.6M

Recent Changes

Fee Change: ↓ 2.2%

Available Change: ↓ 4.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime